Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Moringa mouthwash is an investigational herbal oral rinse containing an extract of *Moringa oleifera* leaves, specifically being developed and studied by Nahda University in Egypt. The formulation is prepared using a 90% ethanol extraction process to isolate bioactive compounds including alkaloids, flavonoids, tannins, terpenoids, glycosides, and saponins. It is primarily indicated for the prevention and treatment of dental caries in children by leveraging its antimicrobial properties against *Streptococcus mutans*, the primary causative bacterium of tooth decay. The mouthwash aims to reduce bacterial counts and inhibit the formation of biofilms on tooth surfaces. It has been evaluated in clinical trials at various concentrations (5%, 10%, and 15%) to determine the optimal antibacterial potency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Moringa mouthwash.